| Red blood cell microvesicles activate the contact system, leading to factor IX activation via 2 independent pathways DF Noubouossie, MW Henderson, M Mooberry, A Ilich, P Ellsworth, ... Blood, The Journal of the American Society of Hematology 135 (10), 755-765, 2020 | 73 | 2020 |
| Red blood cells modulate structure and dynamics of venous clot formation in sickle cell disease C Faes, A Ilich, A Sotiaux, EM Sparkenbaugh, MW Henderson, L Buczek, ... Blood, The Journal of the American Society of Hematology 133 (23), 2529-2541, 2019 | 62 | 2019 |
| Expression and antimicrobial function of beta-defensin 1 in the lower urinary tract B Becknell, JD Spencer, AR Carpenter, X Chen, A Singh, S Ploeger, ... PloS one 8 (10), e77714, 2013 | 55 | 2013 |
| Development and application of global assays of hyper‐and hypofibrinolysis A Ilich, DF Noubouossie, M Henderson, P Ellsworth, KF Molitor, ... Research and Practice in Thrombosis and Haemostasis 4 (1), 46-53, 2020 | 25 | 2020 |
| Pregnancy in sickle cell trait: what we do and don’t know S Wilson, P Ellsworth, NS Key British Journal of Haematology 190 (3), 328-335, 2020 | 20 | 2020 |
| Factor-mimetic and rebalancing therapies in hemophilia A and B: the end of factor concentrates? P Ellsworth, A Ma Hematology 2021 (1), 219-225, 2021 | 18 | 2021 |
| Recombinant porcine FVIII for bleed treatment in acquired hemophilia A: findings from a single-center, 18-patient cohort P Ellsworth, SL Chen, RS Kasthuri, NS Key, MJ Mooberry, AD Ma Blood Advances 4 (24), 6240-6249, 2020 | 16 | 2020 |
| Emicizumab reduces re‐hospitalization for bleeding in acquired haemophilia A. SL Chen, P Ellsworth, RS Kasthuri, S Moll, AD Ma, NS Key Haemophilia 27 (4), 2021 | 9 | 2021 |
| High molecular weight kininogen contributes to early mortality and kidney dysfunction in a mouse model of sickle cell disease EM Sparkenbaugh, M Kasztan, MW Henderson, P Ellsworth, PR Davis, ... Journal of Thrombosis and Haemostasis 18 (9), 2329-2340, 2020 | 8 | 2020 |
| Targeting the von Willebrand Factor–ADAMTS-13 axis in sickle cell disease P Ellsworth, EM Sparkenbaugh Journal of Thrombosis and Haemostasis 21 (1), 2-6, 2023 | 3 | 2023 |
| Raise the roof, build the floor LH Pecker, P Ellsworth Blood, The Journal of the American Society of Hematology 140 (13), 1453-1455, 2022 | 2 | 2022 |
| Rituximab monotherapy is effective for inhibitor eradication with concomitant porcine factor viii followed by emicizumab for bleed control in acquired hemophilia A P Ellsworth, SL Chen, C Wang, NS Key, A Ma Blood 138, 348, 2021 | 2 | 2021 |
| Emicizumab promotes factor Xa generation on endothelial cells AM Fager, P Ellsworth, NS Key, DM Monroe, M Hoffman Journal of Thrombosis and Haemostasis 22 (6), 1605-1615, 2024 | 1 | 2024 |
| Sevuparin trial for acute pain in sickle cell disease: the dog that did not bark P Ellsworth, JA Little The Lancet Haematology 8 (5), e307-e309, 2021 | 1 | 2021 |
| Recombinant Porcine Factor VIII Use in Bleed Treatment in Non-Severe Hemophilia a Inhibitor Patients: Dosing Strategies and Efficacy P Ellsworth, SL Chen, YL Abajas, S Moll, NS Key, AD Ma Blood 132, 1202, 2018 | 1 | 2018 |
| Recombinant Porcine FVIII in Acquired Hemophilia: Decreased Product Usage When Used Upfront, Non-Utility of Baseline Porcine Bethesda Titer, and Confirmation of Dosing Algorithm P Ellsworth, SL Chen, NS Key, RS Kasthuri, MJ Mooberry, AD Ma Blood 132, 2474, 2018 | 1 | 2018 |
| P246: Challenges in establishing best practices for gene therapy informed consent for hemophilia A/B K Lee, C Berkowitz, K Jackson, B Nielsen, P Ellsworth, A Ma, N Key Genetics in Medicine Open 2, 2024 | | 2024 |
| Hypertonicity and/or Acidosis Induce Marked Rheological Changes Under Hypoxic Conditions in Sickle Trait Red Blood Cells P Ellsworth, I Pawlinski, R Sielaty, A Ilich, C Moonla, Y Prokopenko, ... Blood 142, 1113, 2023 | | 2023 |
| My ASH “Mix Tape”: The Best of ASH Nonmalignant Sessions P Ellsworth | | 2021 |
| Hemostasis Highlights: I Really Am a Spoiled Millennial (Clinically Speaking) P Ellsworth | | 2021 |
Nigel KeyHarold R Roberts Distinguished Professor of Medicine, University of North Carolina at Chapel Hill在 med.unc.edu 的电子邮件经过验证
